Tegsedi Clinical Development Timeline

 
• By Sue Sutter

Chronicle of the development and US FDA review of Ionis Pharmaceuticals’ inotersen for treatment of polyneuropathy of hATTR amyloidosis.

More from Drug Review Profiles

More from Product Reviews